TABLE 1.
Source | Country | Participant Profile | How Adherence Is Assessed | Main Factors Addressed for Primary Nonadherence | |||||
---|---|---|---|---|---|---|---|---|---|
Final Sample Size | Sample Description | Patient Factors | Medication Factors | Health Care Provider Factors | Health Care System Factors | Socioeconomic Factors | |||
Adamson et al. (2017)14 | United States | 2,496 | New dermatology patients with 1 or more medications prescribed | Electronic medical records and pharmacy claims records | Higher PNA among younger patients Age factor differs in men and women |
Number of dispensed drug (polypharmacy) Cost, especially for elderly patients |
– | Method of prescription (electronic prescription vs. paper prescription) Infrastructure to accommodate the needs of non-English-speaking patients |
– |
Bauer et al. (2013)22 | United States | 1,366 | Adults aged 30-75 years with type 2 diabetes who were prescribed a new antidepressant during 2006-2010 | Pharmacy claims records | Health literacy and race/ethnicity | – | – | – | Patients with health literacy limitations have poorer adherence |
Cheetham et al. (2013)15 | United States | 19,826 | Patients aged ≥ 24 years with a new statin prescription (having no statin prescriptions in the previous 12 months) in a large integrated health care delivery system | Electronic medical records | Younger and healthier patients, with fewer comorbid conditions, lower rates of hospitalization, fewer clinic and emergency department visits in previous year | Fewer concurrent prescriptions | – | – | – |
da Costa et al. (2015)20 | Portugal | 375 | Patients aged ≥ 15 years with chronic medical conditions and a prescription of at least 1 drug for diabetes, hypertension, or hyperlipidemia | Questionnaire study and data of medication collection from pharmacist | Higher nonadherence among women for antidiabetic medication | Availability of medication at home Higher nonadherence among women for antidiabetic medication |
– | – | Financial problems faced by patients |
Fallis et al. (2013)33 | Canada | 232 | Patients aged ≥ 66 years, discharged from the general internal medicine service of a hospital | Claims data in Drug Profile Viewer | – | – | More likely among patients discharged to nursing homes | – | – |
Harrison et al. (2013)28 | United States | 98 | Patients aged ≥ 24 years, with no record of redeeming a new statin medication within 1 to 2 weeks of being ordered | Phone interview data; self-reported nonadherence | Concerns about taking the medication Patients’ preference for lifestyle modification (e.g., diet and exercise) instead of taking medication Fear of side effects Patients’ perceived redundancy and ineffectiveness of medication |
– | Lack of communication between patient and physician | Financial hardships Inadequate health literacy |
|
Jackevicius et al. (2008)19 | Canada | 4,591 | Acute myocardial infarction (AMI) patients aged ≥ 66 years, enrolled in the Enhanced Feedback for Effective Cardiac Treatment (EFFECT) study registry |
The EFFECT study registry and the AMI charts it collects from 104 acute care hospitals in Ontario | Patients’ perceived ineffectiveness and redundancy of medication Older patients |
Patients with more pre-AMI/baseline prescriptions | Patients who do not receive medication counseling and education after discharge Patients who do not have a cardiologist as the most responsible physician |
– | – |
Jackson et al. (2014)16 | United States | 29,238 | Adult patients aged ≥ 18 years, with a new electronic prescription for medications intended to treat chronic conditions, as supplied by the Pharmacy Quality Alliance (PQA) | Prescription data from 100 retail pharmacies | Slightly younger in age: 59.42 vs. 59.60 years | PQA-defined drug class (e.g., high nonadherence is observed for antiretrovirals) Higher out-of-pocket costs for medication Prescriptions accompanied by another prescription on the same day |
Higher nonadherence when prescriber is neither a physician (both specialist and primary care), physician assistant, or advanced practice nurse Nonadherence more likely to occur in pharmacies with lower prescription volumes |
– | Higher nonadherence when prescriptions originate in pharmacies located in neighborhoods with higher household incomes and educational levels |
Karter et al. (2010)29 | United States | 169 | Patients with type 2 diabetes receiving a new electronic prescription for insulin—those who are primary adherent and primary nonadherent | Data from computer-assisted interviews and self-administered mailed surveys | Patients’ decision to improve other health behaviors instead of insulin-taking Patients’ perceived negative impact on social and work life Injection phobia Concerns about side effects |
– | Lack of provider-patient communication and explanation of the potential risks and benefits associated with insulin Inadequate shared decision making between provider and patient Lack of insulin self-treatment training for patients |
– | – |
Polinski et al. (2014)25 | United States | 26 | Patients aged ≥ 25 years with PNA for anti-hypertensive medications | Focus group discussions | Patients’ misperception about medication Fear of side effects Patients’ distrust of health care provider Suspicion of provider’s diagnosis and motivation to prescribe |
Cost Complexity of medication regimen (polypharmacy) |
Poor communication between physician and patient | – | – |
Pottegård et al. (2014)8 | Denmark | 146,959 | Patients aged ≥ 18 years with free and direct access to general practitioners | Pharmacy records and prescription registry data | Female Younger patients aged 18-29 years Patients with a diagnosis of ischemic heart disease are less adherent Patients with a diagnosis of chronic obstructive pulmonary disease are more adherent |
Polypharmacy | – | – | Highest PNA among patients who earn < 250,000 Danish krone per year |
Raebel et al. (2011)7 | United States | 12,061 | Members of an integrated health delivery system, with a newly initiated order for an antihypertensive, antidiabetic, or anti-hyperlipidemic medication | Electronic health records within an integrated system | – | PNA varied by therapeutic class—highest among those who ordered antihyperlipidemic medications and lowest among those who ordered anti-hypertensive medications | PNA lower for antihyperlipidemic medications prescribed by a provider in a nonprimary care department | – | – |
Rashid et al. (2017)17 | United States | 9,050 | Patients aged ≥ 18 years with new overactive bladder prescriptions | Electronic medical records | Female Younger patients aged 56.9 years on average, compared with the overall average age of 62.6 years Patients who have fewer comorbid conditions (i.e., generally healthier otherwise) Race other than white |
Patients who have fewer concomitant medications and prescriptions dispensed in the past year | – | Patients who have commercial insurance compared with those with Medicaid and Medicare | – |
Reynolds et al. (2013)30 | United States | 8,454 | Women aged ≥ 55 years with a new prescription of oral bisphosphonates | Electronic medical records | Older women with prior emergency department visits Patients’ perceived need for and benefits and risks associated with medication |
– | Prescriptions written by providers with 10 or more years of experience more likely to be redeemed | – | – |
Shin et al. (2012)5 | United States | 569,095 new prescriptions (398,025 patients) | New prescriptions written for 10 therapeutic drug groups in a 3-month period | Electronic medical records | Black and Hispanic patients Patients naive to therapy and treatment Patients with baseline comorbidities Patients who redeem at least 1 prescription in the previous year or had a prescription for symptomatic disease Younger patients more likely to fill acute medication; less likely for chronic medication |
Types of drug group Regimen complexity Cost of medication (only when disease is acute) |
– | – | – |
Storm et al. (2008)21 | Denmark | 322 | Outpatients of a public hospital dermatology department, who receive a prescription for an initial treatment with a previously untried medication | Electronic pharmacy register | Patients with chronic diseases (e.g, eczema) less adherent than patients with short-term diseases (e.g., infections) Men more adherent than women Elderly patients the most adherent Patients with topical treatment (compared with those with systemic treatmenta) less adherent |
– | Better adherence among patients who see specialists rather than junior physicians | – | – |
Thengilsdóttir et al. (2015)6 | Iceland | 10,685 | Adult patients aged ≥ 18 years from the capital area in Iceland who received a new statin or antidepressant prescription within the study period | Prescription database records | Vulnerable groups of patients with disabilities prescribed expensive drugs Women and younger patients |
Patients prescribed SNRIs and atorvastatin compared with those prescribed SSRIs and simvastatin | – | – | – |
Wamala et al. (2007)31 | Sweden | 31,895 | Patients aged 21-84 years who corresponded with a physician at a hospital or primary care center within a 3-month period | Self-reported nonadherence using postal self-administered questionnaire | – | – | – | Sweden’s “care on equal terms” health policies (publicly funded health care system and subsidized medication) less successful among socio-economically disadvantaged elderly patients | Patients placed lower on the socioeconomic index, especially elderly women |
Williams et al. (2007)23 | United States | 1,064 | Asthma patients aged 5-56 years, with at least 1 electronic prescription for inhaled corticosteroids and at least 3 months follow-up after the prescription | Electronic prescription information and pharmacy fill data | Low baseline rescue medication use Lower perceived need for medication Race and ethnicity |
– | Frequency of contact between patient and physician, especially for African American patients | – | – |
Wooldridge et al. (2016)24 | United States | 341 | Adult patients who were hospitalized for cardiovascular events, had new discharge prescriptions to fill post-discharge, and had received study intervention about filling discharge prescriptions | Secondary analysis of data from a randomized, controlled trial evaluating the effect of tailored intervention in adults hospitalized for acute coronary syndromes or acute decompensated heart failure | Single marital status | Polypharmacy (having more than 10 total discharge medications) | Not applicable as patients have undergone tailored intervention of pharmacy-assisted medication reconciliation, discharge counseling, low-literacy adherence aids, and follow-up phone calls | – | Low income: inability to afford medication cost and also faced transportation limitations |
Wroth et al. (2006)18 | United States | 3,926 | Adult aged ≥ 18 years, having lived in the southeastern rural community for more than 1 year, and visited a health care provider in the previous year | Phone survey data; self-reported non-adherence | Patients aged < 65 years African American Patients with transportation problems Trust and confidence in patient-physician relationship Patients’ satisfaction with care provided |
– | Trust and confidence in patient-physician relationship Patients’ satisfaction with care provided Patient-physician concordance on medication |
– | Annual income of < $25,000 |
Yu et al. (2015)26 | United States | 430 | Women aged ≥ 55 years with an untreated osteoporosis diagnosis (i.e., no claims for osteoporosis-specific medication) | Mail survey data | Concern over side effects of medication Patients’ beliefs about osteoporosis and osteoporosis medication |
– | – | Cost of medication: contribution of insurance to medication costs | – |
aUsing substances that travel through the bloodstream, reaching and affecting cells all over the body.
PNA = primary nonadherence; SNRI = serotonin-norepinephrine reuptake inhibitor; SSRI = selective serotonin reuptake inhibitor.